[1] |
ZHAI Haihui, LIU Yuanqi, ZHANG Congzheng, GUAN Liping, HAN Tao.
The latest research progress on P53 and tumor metabolism
[J]. China Oncology, 2023, 33(11): 1032-1040.
|
[2] |
ZOU Chunyuan, XU Xiaofeng, LU Renquan, GUO Lin.
Detection of p53, PGP9.5, SOX2, GAGE7, GBU4-5 and MAGE A1 protein levels in lung cancer tissues and peripheral blood and their clinical value
[J]. China Oncology, 2023, 33(1): 36-44.
|
[3] |
ZHOU Changshuai, YANG Yuechao, CUI Huanhuan, CHEN Lei, CHEN Xin, HAO Bin, TONG Tong, CAO Yiqun.
Prognostic factor analysis of surgical treatment for cerebellar metastases in 36 patients
[J]. China Oncology, 2022, 32(4): 357-362.
|
[4] |
CHEN Xi, ZENG Xiaoying, CHEN Jiayan, LIU Fei, TANG Xi.
The clinical value of mismatch repair protein combined with serum tumor markers and Ki-67 proliferation index in the prognostic evaluation of colorectal cancer
[J]. China Oncology, 2022, 32(3): 243-250.
|
[5] |
QIU Xiaoyang , WANG Shaohong , ZHENG Jing , WU Xuan , WANG Yuanyuan , LIU Jun , YE Caiguo .
Predictive value of immunocytochemical p16/Ki-67 double staining for cervical cytology negative and HR-HPV positive shunting and histological LSIL prognosis
[J]. China Oncology, 2020, 30(7): 512-518.
|
[6] |
ZHU Xiaojian, LIN Kang, BU Fanqin, LUO Chen, HUANG Chao, ZHU Zhengming.
High expression of DJ-1 promotes growth and invasion of colorectal cancer cells via the cyclin D1/p53-MDM2-AKT signaling pathway
[J]. China Oncology, 2020, 30(3): 208-216.
|
[7] |
XU Xiaoyan , WANG Jianjun , WANG Hui , WANG Na , LIU Wei , YANG Jinhua .
Quantitative detection of JMJD3 and Ki-67 in invasive ductal carcinoma of breast and their relationship with molecular typing and clinicopathological features
[J]. China Oncology, 2020, 30(1): 57-63.
|
[8] |
REN Chunxia,XIA Xiaoai,YANG Shudong,LV Bei,TONG Guoqing .
Establishment and initial analysis of an immortalized human ovarian surface epithelial cell line carrying a BRCA1 mutation
[J]. China Oncology, 2019, 29(9): 693-699.
|
[9] |
XUE Jincai, LIU Qinjiang, TIAN Youxin, et al.
The value of BRAFV600E and TERT promoter mutation in risk assessment of papillary thyroid microcarcinoma
[J]. China Oncology, 2018, 28(5): 335-341.
|
[10] |
DONG Yinan, KONG Fanming, ZHANG Xinwei, et al.
iASPP-SV, as an oncogene, participates in breast tumorigenesis and progression
[J]. China Oncology, 2016, 26(10): 831-839.
|
[11] |
JIANG Qiqi, ZHANG Hongmei, GUO Ai, et al.
Effect and mechanism of rmhTNF on gastric cancer cell lines with different Δ133p53 status
[J]. China Oncology, 2015, 25(4): 287-293.
|
[12] |
ZHANG Yanna, XIA Wen, SUN Qiang, et al.
The expression and relationship between FOXA1 and ERβ in triple negative breast cancer
[J]. China Oncology, 2015, 25(4): 253-259.
|
[13] |
GUO Ai, JI Wansheng, JIANG Qiqi et al.
The role of Δ133p53 during 5-FU inhibition experiments on the growth of gastric cancer cell line MKN45
[J]. China Oncology, 2015, 25(1): 25-30.
|
[14] |
JIA Xiao-qing, HONG Qi, CHENG Jing-yi, LI Jian-wei, WANG Yu-jie, MO Miao, SHAO Zhi-min, SHEN Zhen-zhou, LIU Guang-yu.
Overexpression of P53 is prognostic for aromatase inhibitor resistance in early stage postmenopausal patients with ER-positive breast cancer
[J]. China Oncology, 2014, 24(5): 354-360.
|
[15] |
GAO Wen, ZANG Rong-yu, WANG Yan, YANG Li-na, LIU Yang, QI Zi-hao, YIN Sheng, YANG Gong.
Immortalization of human fallopian tube epithelial cells
[J]. China Oncology, 2013, 23(4): 241-247.
|